IPHA News

After a busy week in the IPO market, just one biotech is scheduled to go public in the week ahead. NASH biotech 89bio (ETNB) plans to raise $85 million at a $225 million market cap. The company’s target indication represents a multi-billion-dollar market with no FDA-approved therapy; consequently, there are ...read more

Two companies and two SPACs entered the public market this week, while Karat Packaging (KRAT) postponed and withdrew its $40 million IPO. Two companies and one SPAC submitted initial filings. Post spin-off BellRing Brands (BRBR) priced its $480 million IPO well below the range to command a $1.8 billion market cap (-17% v. original midpoint). BellRing came...read more

Innate Pharma, a commercial-stage French biotech developing antibody therapies for cancer, raised $69 million by offering 12.5 million shares at $5.50 (€4.97), a 13% discount to its prior closing price on the Euronext Paris (€5.71; ticker IPH). Innate originally filed to offer 10.7 million shares at $7.50 per share. Innate Pharma plans to list on the Nasdaq under the...read more

After disappointing debuts from tech unicorns and biotechs, a highly profitable billion-dollar consumer staples company is set to lead up to four IPOs raising $660 million in the week ahead. Post spinoff BellRing Brands (BRBR) is on track to be the largest deal of the week with plans to raise $525 million at a $2.2 billion market cap ($3.0 billion enterprise...read more